Catalyst Pharmaceuticals Inc

XNAS: CPRX

Strong Performer, Getting Expensive

Download real time

24.23 1.07 (4.62%)

Near 52W High of $24.64

4.9M XNAS Volume

High volume today

XNAS 21 Mar, 2025 5:30 PM (EDT)

2,942.7

Market Cap

High in industry

0.2

Beta 1Year

Very Low volatility

Catalyst Pharmaceuticals Inc - CPRX - stock price prediction, stock price target, analyst ratings from 9 analysts

Catalyst Pharmaceuticals Inc has a share price target of US$ 33, revenue growth forecast of 12.9%, and profit growth estimate of 10.5% for FY25, based on top 9 analyst calls.

Forecaster Screeners